Business

Announcement on Voluntary Disclosure of Obtaining Notice of Approval of Drug Clinical Trial for Holding Subsidiary's Product SCTB39G

Announcement on Voluntary Disclosure of Obtaining Notice of Approval of Drug Clinical Trial for Holding Subsidiary's Product SCTB39G

articleSinocelltech Group Limited Class AJune 25, 20254/news/announcement-on-voluntary-disclosure-of-obtaining-notice-of-approval-of-drug-clinical-trial-for-holding-subsidiarys-product-sctb39g
Announcement on Voluntary Disclosure of Obtaining Notice of Approval of Drug Clinical Trial for Holding Subsidiary's Product SCTB39G

About this update from Sinocelltech Group Limited Class A

Announcement on Voluntary Disclosure of Obtaining Notice of Approval of Drug Clinical Trial for Holding Subsidiary's Product SCTB39GThe abstract is for reference only. Please refer to the full text of the announcement on the very day.Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Sinocelltech Group Limited Class A